{"prompt": "['Charit\u00e9 Universit\u00e4tsmedizin Berlin', 'Prof. Dr. med. Dominik Modest', 'FIRE-9 PORT', '28-Sep-2021', 'EudraCT no. 2020-006144-18', 'Protocol Version 3.0', '2.3 Schedule of Trial Activities', 'Table 1: Schedule of Activities', 'Pre-study', 'Screening and', 'Structured Follow-up (Arm A and B)', 'Trial Period:', 'SOC', 'Randomization', 'intervention*', 'Phase', '+ Trial Intervention (Arm A only)', 'Inclusion is', 'up to 10', 'possible 3-10', 'at least 60mo.', 'weeks', 'weeks after the', '3mo.', '6mo.', '9mo. 24mo.', 'after random. or', 'Timing and assessment window:', 'prior to', 'SOC intervention', 'random.', '( 2w)', '( 2w)', '(q3mo. 2w)\u00a7', 'until death', 'after successful', '(q6mo. 1mo.)', 'screening', 'Administrative Procedures', 'Definite treatment of colorectal cancer metastases', 'A/B', 'Informed Consent', 'A/B', 'Inclusion/Exclusion Criteria', 'A/B', 'Demographics and Medical History', 'A/B', 'Prior and Concomitant Medication Reviewa', 'A/B', 'A', 'Prior FOLFOX(IRI) or CAPOX/XELOX therapy', 'A/B', 'Randomization', 'A/B', 'Clinical Procedures/Assessments', 'ECOG Performance Status', 'A/B', 'A/B', 'A/B', 'A/B', 'Full Physical Examinationb)', 'A/B', 'A+', 'Directed Physical Examination', 'A', '(A)', 'Review Adverse Eventsc', 'A/B', 'A/B', 'A/B', 'Heightd, Weight and Vital Signs (T, P, BP)', 'A/B', 'A', '(A)', 'A+', '12-Lead Electrocardiograme', 'A/B', 'A', 'A', 'A+', 'Covid-19 assessment', 'A/B', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'Confidential', 'Page 22 of 79']['Charit\u00e9 Universit\u00e4tsmedizin Berlin', 'Prof. Dr. med. Dominik Modest', 'FIRE-9 PORT', '28-Sep-2021', 'EudraCT no. 2020-006144-18', 'Protocol Version 3.0', 'Pre-study', 'Screening and', 'Structured Follow-up (Arm A and B)', 'Trial Period:', 'SOC', 'Randomization', 'intervention*', 'Phase', 'Trial Intervention (Arm A only)', 'Inclusion is', 'up to 10', 'possible 3-10', 'at least 60mo.', 'weeks', 'weeks after the', '3mo.', '6mo.', '9mo. 24mo.', 'after random. or', 'Timing and assessment window:', 'prior to', 'SOC intervention', 'random.', '( 2w)', '( 2w)', '(q3mo. 2w)s', 'until death', 'after successful', '(q6mo. 1mo.)', 'screening', 'mFOLFOXIRI or mFOLFOX-6 or de-escalated', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'A', 'treatment regimens, if applicable (q14d + 5d)f', 'Further anticancer therapy status', 'A/B', 'Survival Status', 'A/B', 'A/B', 'A/B', 'A/B', 'Laboratory Procedures/Assessments', 'Pregnancy Test - Urine or Serum', 'A/B', 'A', 'A', 'A', 'A', 'A', 'A', 'A+', 'PT/INR and aPTTh)', 'A/B', '(A)', 'CBC with Differentiali),j)', 'A/B', 'A', '(A)', 'A+', 'Comprehensive Serum Chemistry Paneli,', 'A/B', 'A', '(A)', 'A+', 'Quality of Life', 'EQ5D5L Questionnaire', 'A/B', 'A/B', 'A/B', 'A/B', 'A/B', 'Efficacy Measurements', 'Tumor Imaging and CEA', 'A/B', 'A/B\u00b9', 'A/Bm)', 'A/Bm)', 'A/Bm)', 'A/Bn', 'Tumor Biopsies/Archival Tissue Collection/Correlative Studies Blood', 'Archival or Newly Obtained Tissue Collection /', 'A/B\u00b0)', 'A/BP)', 'Biopsy', 'Correlative Biomarker Studies / Blood Collection\u00b0', 'A/B', 'A/B', 'A/B', 'A/B', '#', 'Pre-study treatment of colorectal cancer metastases by ablation/radiation should be performed to study site specific routine and is considered SOC.', 'Confidential', 'Page 23 of 79']\n\n###\n\n", "completion": "END"}